Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of Circulating Tumor DNA Detection in Surveillance for Lung Cancer Patients

NCT03081741 is registered in ClinicalTrials.gov with Shenzhen Gene Health Bio Tech Co., Ltd. as lead sponsor.

NCT NCT03081741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03081741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of Circulating Tumor DNA Detection in Surveillance for Lung Cancer Patients
Lead sponsor
Shenzhen Gene Health Bio Tech Co., Ltd.
Phase
Observational
Overall status
Unknown status
Start date
May 3, 2017
Completion date
March 18, 2020
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung neoplasms